ASIRO (7378) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Revenue grew 45% YoY in FY2024 2Q, reaching ¥2,126 million, driven by strong legal and derivative media segments.
Operating loss of ¥41 million, reversing from a prior-year profit, mainly due to impairment losses and increased investment.
Net profit attributable to owners was ¥4 million for 2Q, but a net loss of ¥124 million for the cumulative period due to impairments.
All business segments posted YoY revenue growth, with especially strong performance in derivative media and HR businesses.
The company is in a planned investment phase, prioritizing long-term growth over short-term profitability.
Financial highlights
2Q revenue: ¥1,160 million (+45.1% YoY, +20.1% QoQ); 2Q cumulative revenue: ¥2,126 million (+43.1% YoY).
2Q operating profit: ¥62 million (including ¥67 million impairment loss); cumulative operating loss: -¥41 million (impairments totaling ¥203 million).
EBITDA increased 22.6% YoY to ¥224 million; adjusted EBITDA up 23.2% to ¥181 million.
Gross margin for 2Q: 36.8% (down 4.9pt YoY); gross profit margin for the period: 35.4%.
2Q-end cash and deposits: ¥1,235 million; operating cash flow turned positive at ¥228 million.
Outlook and guidance
Full-year revenue guidance maintained at ¥4,236 million (+32.5% YoY), with 2Q results at 50.2% of annual target.
Operating profit forecast is ¥105 million (+97.8% YoY); net profit forecast is ¥6 million, EPS ¥3.59.
Profit targets are expected to be met, with investment levels under control and impairment losses now fully recognized.
No change to previously announced guidance.
Focus will shift to new product development in insurance, with existing product promotion investment curtailed.
Latest events from ASIRO
- Revenue up 8.9% YoY, profit down, dividend policy revised, and HR business divested.7378
Q1 202623 Mar 2026 - Record revenue and profit growth, HR dispatch divested, and AI-focused strategy launched.7378
Q2 202511 Dec 2025 - Record profit growth and business focus drive strong FY2025 results and positive FY2026 outlook.7378
Q4 202511 Dec 2025 - Record profit and margin growth, guidance raised, and new insurance product launched.7378
Q3 202512 Sep 2025 - Revenue and profit soared past targets; FY2025 outlook signals major earnings growth.7378
Q4 202413 Jun 2025 - Revenue up 44% YoY, impairments led to net loss, but outlook was raised.7378
Q3 202413 Jun 2025 - Record Q1 growth, robust segment gains, and a major business update ahead.7378
Q1 20256 Jun 2025